title: Highlights in acute myeloid leukemia from the 2012 meeting of the American Society of Hematology.
abstract: The American Society of Hematology Annual Meeting includes physicians, scientists, administrators, medical students, graduate students, allied health professionals and exhibitors. This year's meeting was held in Atlanta, GA, USA. Presentations included a wide variety of topics in benign and malignant hematology.
authors.affiliation: Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Avenue, M1B-17, Boston, MA 02215, USA. rstone@partners.org
authors.forename: Richard M
authors.initials: RM
authors.lastname: Stone
mesh_terms: D018943:Anthracyclines / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D006801:Humans; D015255:Idarubicin / Q000627:therapeutic use; D015470:Leukemia, Myeloid, Acute / Q000175:diagnosis / Q000188:drug therapy*; D012958:Societies, Scientific; D014212:Tretinoin / Q000627:therapeutic use*; D014481:United States; D051941:fms-Like Tyrosine Kinase 3 / Q000037:antagonists & inhibitors / Q000378:metabolism
chemical_list: D018943:Anthracyclines; D000970:Antineoplastic Agents; D014212:Tretinoin; C497970:FLT3 protein, human; D051941:fms-Like Tyrosine Kinase 3; D015255:Idarubicin